How Two Life Science Leaders Unlocked Pharma 4.0 Success

By Torey Penrod-Cambra, Chief Communications Officer at HighByte

Life science manufacturers are striving to increase their agility and utilize data more effectively to drive business growth. However, the pressures in this sector are unique. Products have a profound impact on human life, tolerance is stringent, regulatory demands are intensifying, and the cost of failure is high. These pressures make the adoption of new technologies more complex than in other industrial sectors. When deploying new systems, companies must navigate the constraints posed by existing processes, tools, and IT infrastructure.

This situation creates an "agility paradox," where processes must be rigorously controlled while analytics demand a real-time, iterative approach. Additionally, these constraints can lead to escalating and unpredictable costs associated with cloud data ingestion and processing, as well as the inefficient use of human resources. Consequently, many life science manufacturers continue to face difficulties in scaling their Pharma 4.0 initiatives beyond the pilot stage. Nevertheless, some life sciences manufacturers are finding success and paving the way forward. Gain valuable insights from a panel discussion organized by ABI Research featuring digitalization leaders from Alcon and Catalent.